CIK 0001723128
- Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 908-947-3120
- Former names
- Atlas Holdings, Inc.
- 4 Open-market sale Executive Vice President sold 71,694 shares at $9.29 ($666,037)
- 4 Open-market sale Executive Vice President & CFO sold 499,730 shares at an average $9.33 ($4,663,070)
- 4 Open-market sale Executive Vice President sold 50,000 shares at $9.04 ($452,000)
- 4 Open-market sale EVP, Chief Legal Officer sold 22,000 shares at $9.05 ($199,100)
- 4 Open-market sale Executive Vice President sold 33,436 shares at $9.05 ($302,596)
- 4 Planned sale Director sold 94,906 shares at $8.02 ($761,146)
- 4 Open-market sale Director sold 56,426 shares at $8.02 ($452,537)
- 4 Open-market sale Executive Vice President sold 49,140 shares at $7.58 ($372,481)
- 4 Open-market sale Director sold 50,000 shares at $7.59 ($379,500)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Option exercise Director acquired 56,361 shares (option exercise)
- 4 Option exercise Director acquired 40,258 shares (option exercise)
- 4 Open-market sale Director sold 8,668 shares at $8.00 ($69,344)
- 4 Open-market sale Director sold 80,000 shares at $8.30 ($664,000)
Page 3 of 18 · 351 filings